CHRISTIAN S SCHADE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTIAN S SCHADE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTIAN S SCHADE. CHRISTIAN S SCHADE is a Director in INTEGRA LIFESCIENCES HOLDINGS CORP ($IART) and a SVP & CFO in MEDAREX INC ($MEDX) and a Chairman & CEO in Aprea Therapeutics, Inc. ($APRE) and a President & CEO in Aprea Therapeutics, Inc. ($APRE).
Address: MEDAREX, INC. 707 STATE ROAD PRINCETON 08540 NJ
Companies in which CHRISTIAN S SCHADE is an Insider
Aprea Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTIAN S SCHADE: Chairman & CEO, President & CEO
Holdings: 77,160 shares
Latest Transaction: Mar 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTEGRA LIFESCIENCES HOLDINGS CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of CHRISTIAN S SCHADE: Director
Holdings: 36,418 shares
Current Value: $1,543,759
Latest Transaction: May 20 2019
$IART Market Capitalization: $3.18B
$IART Previous Close: $42.39
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDAREX INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of CHRISTIAN S SCHADE: SVP & CFO
Holdings: 0 shares
Latest Transaction: Sep 03 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CHRISTIAN S SCHADE
Sentiment: All, APRE, IART, MEDX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | Chairman & CEO | Option Exercise | A | 6.00 | 329,000 | 1,974,000 | 329,000 | |
| Mar 01 2021 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | Chairman & CEO | Grant | A | 0.00 | 88,500 | 0 | 176,660 | 88.2 K to 176.7 K (+100.39 %) |
| Mar 01 2021 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | Chairman & CEO | Grant | A | 0.00 | 77,000 | 0 | 77,160 | 160 to 77.2 K (+48,125.00 %) |
| Mar 26 2020 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Option Exercise | A | 35.50 | 127,000 | 4,508,500 | 127,000 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Option Exercise | A | 15.00 | 306,085 | 4,591,275 | 306,085 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Option Exercise | A | 15.00 | 306,085 | 4,591,275 | 306,085 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | SCHADE CHRISTIAN S | President & CEO | Buy | P | 15.00 | 5,000 | 75,000 | 5,000 | 0 to 5 K |